About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 70043 record(s)
Req # A-2020-001457
Information on drug Epival. All records of all side effects from drug Epival reported by medical facilities, hospitals and institutions to Health Canada or adverse health effects. Request by province.Organization: Health Canada
October 2022
Req # A-2021-001284
Disclosable Good Manufacturing Practices (GMP) inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the biologics drug establishment licence GMP foreign regular on-…Organization: Health Canada
October 2022
Req # A-2021-001991
All records utilized by Health Canada when assessing applications for security clearance under the Cannabis Act.Organization: Health Canada
October 2022
Req # A-2022-000054
All material prepared by the Public Health Agency of Canada (PHAC) officials for the meeting between PHAC and the Office of the Privacy Commissioner (OPC) held on 22 April 2020, and of any after-meeting emails or document written by PHAC officials…Organization: Health Canada
October 2022
Req # A-2022-000222
All documents related to Cannabis cultivation, production, research, importation, and exports with and between Jamaican cannabis companies / investments / investors / businesses. Results of any cannabis testing in Canadian Health Canada facilities…Organization: Health Canada
October 2022
Req # A-2022-000232
All records for the past 10 years for the position called Director General Controlled Substances Directorate Health Canada. The number / quantity of individuals holding this job title if more than one.Organization: Health Canada
October 2022
Req # A-2022-000338
Financial information on the Federally Funded Health Information systems in Canada. Total cost / expense broken down by year ending 2017, 2018, 2019, 2020 & 2021 for all money paid on: Federal Health Transfers to provinces. Federal Health IT…Organization: Health Canada
October 2022
Req # A-2022-000393
The initial cover letters indicating the brand name of the reference drug product and the dosage form of the generic drugs in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient micafungin.…Organization: Health Canada
October 2022
Req # A-2022-000463
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient tolvaptan. The…Organization: Health Canada
October 2022
Req # A-2022-000509
The Acknowledgment Letter that would address the most recent status of authorization by Health Canada for the medications named: Aducanumab et LecanemabOrganization: Health Canada
October 2022